Common Stock Dividends Paid (Quarterly)

Common Stock Dividends Paid: The cash outflow for dividends paid on a company's common stock.

AMNEAL PHARMACEUTICALS, INC. (AMRX) Common Stock Dividends Paid data is not available.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$724.51M
Net Income	$22.42M
Cost of Goods Sold	$438.25M
Gross Profit	$286.25M
Operating Expenses	$613.14M
Operating Income	$111.37M
Non-Operating Income/Expense	$-59.66M
Pre-Tax Income	$51.71M
Normalized Pre-Tax Income	$51.71M
Income after Taxes	$35.61M
Income from Continuous Operations	$35.61M
Consolidated Net Income/Loss	$35.61M
Normalized Income after Taxes	$35.61M
EBIT	$111.37M
EBITDA	$178.36M
Weighted-Average Shares Outstanding (Basic)	313.74M
Weighted-Average Shares Outstanding (Diluted)	322.36M
Earnings per Share (EPS) (Basic)	$0.07
Earnings per Share (EPS) (Diluted)	$0.07
Balance Sheet Financials
Current Assets	$1.58B
Property, Plant, and Equipment	$440.33M
Long-Term Assets	$1.84B
Total Assets	$3.42B
Current Liabilities	$1.11B
Long-Term Debt	$2.15B
Long-Term Liabilities	$2.43B
Total Liabilities	$3.54B
Common Equity	$-112.53M
Tangible Shareholders Equity	$-1.36B
Shareholders Equity	$-112.53M
Common Shares Outstanding	314.04M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$91.23M
Cash Flow from Investing Activities	$-44.34M
Cash Flow from Financial Activities	$-80.85M
Beginning Cash	$118.42M
End Cash	$83.67M
Increase/Decrease in Cash	$-34.75M
Stock-Based Compensation	$15.53M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.43
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.06
Debt to Equity Ratio	-21.93
Gross Margin	39.51%
Operating Margin	15.37%
EBIT Margin	15.37%
EBITDA Margin	--
Pre-Tax Profit Margin	7.14%
Profit Margin	3.09%
Free Cash Flow	$51.98M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.21
Inventory Turnover	0.72
Receiveable Turnover	0.90
Days Sales in Receivables	100.52
Return on Equity	-31.64%
Return on Tangible Equity	-2.62%
Return on Assets	1.04%
Return on Investments	1.75%
Book Value Per Share	$-0.36
Free Cash Flow per Share	$0.16
Operating Cash Flow per Share	$0.28

Data from Zacks Investment Research, Inc.